Risk for dementia similar with SGLT2 inhibitors, dulaglutide in T2DM
Aug 26, 2024
The estimated risk difference varied from −2.45 to 0.63 percentage points with SGLT2 versus dulaglutide among older adults.
No spike in schizophrenia, other diagnoses among people with dementia after feds crack down on antipsychotic...
By
Kimberly Marselas
Aug 28, 2024
Federal policies designed to reduce use of antipsychotic medications in nursing homes did not lead to clinically significantly higher rates of schizophrenia diagnoses among people living with dementia,...
Studies highlight increasing dementia deaths, contributing factors to diagnosis and cognitive decline
By
Kimberly Bonvissuto
Aug 16, 2024
More people are dying from dementia, and location and demographics are among the factors that may contribute to not only a dementia diagnosis, but also to how quickly someone will experience cognitive...
Pandemic challenges raise concerns about assisted living’s ability to care for cognitively impaired...
By
Kimberly Bonvissuto
Aug 15, 2024
Exacerbated challenges faced by memory care assisted living communities during the COVID-19 pandemic may have contributed to the increased use of antipsychotics and antidepressants, raising concerns about...
Prevalence of homebound 22 percent in national Medicare Advantage plan
Aug 12, 2024
Homebound status linked to increased odds of ED visit, inpatient admission, skilled nursing-facility admission, mortality
Psychological well-being declines years before diagnosis of MCI
Aug 20, 2024
The findings were seen specifically for the components of purpose in life and personal growth.
Regional variation seen in Alzheimer’s and related dementia diagnosis
Aug 19, 2024
The ADRD-specific diagnosis intensity varies most for Black, Hispanic and youngest subgroups.
Personalized health coaching may improve cognition, lower dementia risk in high-risk older adults
By
Kimberly Bonvissuto
Aug 13, 2024
Personalized dementia risk reduction intervention plans improved cognition and reduced dementia risk among high-risk older adults in a study detailed recently in JAMA Internal Medicine.
Risk for Alzheimer’s dementia lower with treated versus untreated HTN
Aug 14, 2024
The all-cause dementia risk was greater for those with treated and untreated hypertension compared with healthy controls.
Dementia may occur less often, develop slower in Parkinson’s disease patients
Aug 07, 2024
The median time to dementia was 15 years in the Penn cohort; the estimated probability of dementia at year 10 was 9 to 15% in the PPMI cohort.
